Search research articles
Contact Us
Filters
Showing results (51-60 of 70) with videos related to
Page
of 7
Sort By:
American Journal of Therapeutics
|
January 24, 2014
Cardiovascular safety monitoring during oncology drug development and therapy
J Rick Turner, Gopi Krishna Panicker, Dilip R Karnad, et al.
Current Diabetes Reviews
|
December 25, 2014
Addressing unmet medical needs in type 2 diabetes: a narrative review of drugs under development
Friedrich Mittermayer, Erica Caveney, Claudia De Oliveira, et al.
Journal of Clinical Medicine
|
November 7, 2019
Identification of Risk of QT Prolongation by Pharmacists When Conducting Medication Reviews in Residential Aged Care Settings: A Missed Opportunity?
Louise Christensen, J Rick Turner, Gregory M Peterson, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
January 27, 2017
With regard to the papers by Kumar et al. and de Leeuw and de Boer addressing the cardiovascular safety and efficacy of anti-diabetic drugs
J Rick Turner, Erica Caveney, Barbara S Gillespie, et al.
Therapeutic Innovation & Regulatory Science
|
August 31, 2018
Comprehensive In Vitro Proarrhythmia Assay (CiPA) Update from a Cardiac Safety Research Consortium / Health and Environmental Sciences Institute / FDA Meeting
David G Strauss, Gary Gintant, Zhihua Li, et al.
Therapeutic Innovation & Regulatory Science
|
September 18, 2018
Characterization of Missing Data in Clinical Registry Studies
Aaron B Mendelsohn, Nancy A Dreyer, Pattra W Mattox, et al.
Current Diabetes Reviews
|
April 14, 2016
Addressing Unmet Medical Needs in Type 1 Diabetes: A Review of Drugs Under Development
Friedrich Mittermayer, Erica Caveney, Claudia De Oliveira, et al.
American Heart Journal
|
July 27, 2019
Restricted mean survival time for the analysis of cardiovascular outcome trials assessing non-inferiority: Case studies from antihyperglycemic drug development
David H Manner, Chakib Battioui, Stefan Hantel, et al.
American Heart Journal
|
March 31, 2015
Cardiovascular Safety Outcome Trials: A meeting report from the Cardiac Safety Research Consortium
Philip T Sager, Jonathan Seltzer, J Rick Turner, et al.
Journal of Clinical Pharmacology
|
April 20, 2018
Drug-induced Proarrhythmia and Torsade de Pointes: A Primer for Students and Practitioners of Medicine and Pharmacy
J Rick Turner, Ignacio Rodriguez, Emily Mantovani, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 70) with videos related to
Sort By:
Page
of 7
American Journal of Therapeutics
|
January 24, 2014
Cardiovascular safety monitoring during oncology drug development and therapy
J Rick Turner, Gopi Krishna Panicker, Dilip R Karnad, et al.
Current Diabetes Reviews
|
December 25, 2014
Addressing unmet medical needs in type 2 diabetes: a narrative review of drugs under development
Friedrich Mittermayer, Erica Caveney, Claudia De Oliveira, et al.
Journal of Clinical Medicine
|
November 7, 2019
Identification of Risk of QT Prolongation by Pharmacists When Conducting Medication Reviews in Residential Aged Care Settings: A Missed Opportunity?
Louise Christensen, J Rick Turner, Gregory M Peterson, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
January 27, 2017
With regard to the papers by Kumar et al. and de Leeuw and de Boer addressing the cardiovascular safety and efficacy of anti-diabetic drugs
J Rick Turner, Erica Caveney, Barbara S Gillespie, et al.
Therapeutic Innovation & Regulatory Science
|
August 31, 2018
Comprehensive In Vitro Proarrhythmia Assay (CiPA) Update from a Cardiac Safety Research Consortium / Health and Environmental Sciences Institute / FDA Meeting
David G Strauss, Gary Gintant, Zhihua Li, et al.
Therapeutic Innovation & Regulatory Science
|
September 18, 2018
Characterization of Missing Data in Clinical Registry Studies
Aaron B Mendelsohn, Nancy A Dreyer, Pattra W Mattox, et al.
Current Diabetes Reviews
|
April 14, 2016
Addressing Unmet Medical Needs in Type 1 Diabetes: A Review of Drugs Under Development
Friedrich Mittermayer, Erica Caveney, Claudia De Oliveira, et al.
American Heart Journal
|
July 27, 2019
Restricted mean survival time for the analysis of cardiovascular outcome trials assessing non-inferiority: Case studies from antihyperglycemic drug development
David H Manner, Chakib Battioui, Stefan Hantel, et al.
American Heart Journal
|
March 31, 2015
Cardiovascular Safety Outcome Trials: A meeting report from the Cardiac Safety Research Consortium
Philip T Sager, Jonathan Seltzer, J Rick Turner, et al.
Journal of Clinical Pharmacology
|
April 20, 2018
Drug-induced Proarrhythmia and Torsade de Pointes: A Primer for Students and Practitioners of Medicine and Pharmacy
J Rick Turner, Ignacio Rodriguez, Emily Mantovani, et al.
Page
of 7